The landscape of managing diabetes is advancing with the arrival of transdermal GLP-1 delivery . These novel patches offer a possibly more comfortable alternative to needle administrations for individuals dealing with diabetes 2. They deliver a GLP-1 agonist directly through the epidermis, avoidi